Suspension of trading
Oncternal Therapeutics, Inc. Stock
Stocks
ONCT
US68236P2065
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5266 USD | -24.11% |
|
-.--% | - |
| 01/07/25 | Oncternal Therapeutics, Inc. Appoints Craig R. Jalbert as CEO | CI |
| 01/07/25 | Oncternal Therapeutics, Inc. Announces Management Changes | CI |
| Market Cap | 1.56M 1.36M 1.26M 1.18M 2.21M 147M 2.22M 14.97M 5.82M 72.41M 5.85M 5.72M 252M | P/E 2022 |
-1.19x | P/E 2023 | -0.8x |
|---|---|---|---|---|---|
| Enterprise Value | -32.38M -28.29M -26.17M -24.43M -45.86M -3.06B -46.19M -311M -121M -1.5B -122M -119M -5.23B | EV / Sales 2022 |
-4.9x | EV / Sales 2023 | -2.95x |
| Free-Float |
90.77% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | -24.11% |
| 3 years | 0.53 |  | 13.14 |
| 5 years | 0.53 | | 105.4 |
| 10 years | 0.53 | | 211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Vincent
DFI | Director of Finance/CFO | 63 | 01/04/2017 |
Yisrael Katz
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2023 |
Rajesh Krishnan
CTO | Chief Tech/Sci/R&D Officer | 53 | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Hale
CHM | Chairman | 77 | 01/12/2018 |
Dan Kisner
BRD | Director/Board Member | 79 | 07/06/2019 |
William LaRue
BRD | Director/Board Member | 75 | 01/12/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20/06/24 | Free | Director | 2,200 | 0.0743% | ||
| 20/06/24 | Free | Director | 2,200 | 0.0743% | ||
| 20/06/24 | Free | Director | 2,200 | 0.0743% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -24.11% | -.--% | -.--% | -92.89% | 1.56M | |
| +1.60% | +2.99% | -9.23% | -3.89% | 43.24B | |
| +1.73% | +3.59% | +318.08% | +564.04% | 35.25B | |
| +0.61% | +1.34% | +10.00% | +46.20% | 30.22B | |
| +0.02% | -5.93% | +8.45% | -21.44% | 28.01B | |
| -1.06% | -3.71% | +9.08% | +19.56% | 24.08B | |
| -1.23% | +2.11% | - | - | 14.16B | |
| -0.99% | -2.53% | +47.29% | +102.88% | 13.01B | |
| +2.02% | +3.25% | +8.80% | +14.46% | 12.7B | |
| +2.39% | +2.61% | +102.86% | +84.20% | 12.54B | |
| Average | -1.90% | -2.82% | +55.04% | +79.23% | 21.32B | |
| Weighted average by Cap. | +0.70% | -0.20% | +68.27% | +118.36% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.49M 1.3M 1.2M 1.12M 2.11M 141M 2.13M 14.31M 5.57M 69.23M 5.59M 5.47M 240M | 785K 686K 634K 592K 1.11M 74.18M 1.12M 7.54M 2.93M 36.47M 2.95M 2.88M 127M |
| Net income | -44.17M -38.6M -35.7M -33.32M -62.55M -4.17B -63.01M -424M -165M -2.05B -166M -162M -7.13B | -39.48M -34.5M -31.91M -29.78M -55.91M -3.73B -56.32M -379M -148M -1.83B -148M -145M -6.37B |
| Net Debt | -63.64M -55.61M -51.44M -48.01M -90.12M -6.01B -90.78M -611M -238M -2.96B -239M -234M -10.27B | -33.94M -29.65M -27.43M -25.6M -48.06M -3.21B -48.41M -326M -127M -1.58B -127M -125M -5.48B |
Employees
29
- Stock Market
- Stocks
- ONCT Stock
Select your edition
All financial news and data tailored to specific country editions
